RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides

The phrase "RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides" is an administrative or formulary classification label rather than a standardized, distinct therapeutic drug class

The phrase "RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides" is an administrative or formulary classification label rather than a standardized, distinct therapeutic drug class

The phrase "RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides" is an administrative or formulary classification label rather than a standardized, distinct therapeutic drug class

Clinically, it refers to nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs), encompassing both fixed-dose combination formulations and individual single-agent antiretrovirals

Clinically, it refers to nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs), encompassing both fixed-dose combination formulations and individual single-agent antiretrovirals

These pharmacologic agents function as false substrates that compete with natural deoxynucleotides for incorporation into viral DNA, leading to chain termination and inhibition of viral reverse transcriptase activity

In clinical practice, they serve as foundational backbone components for the management and prevention of human immunodeficiency virus type 1 (HIV-1) infection, with select nucleotide analogs also indicated for the treatment of chronic hepatitis B virus infection

In clinical practice, they serve as foundational backbone components for the management and prevention of human immunodeficiency virus type 1 (HIV-1) infection, with select nucleotide analogs also indicated for the treatment of chronic hepatitis B virus infection